Clozapine

Producers shown on SFDA

(Record date:06/09/2021）

Producers shown on EP

(Quoted from EP website；record date:06/09/2021）

Producer:Taizhou Xingming Pharmaceutical Co., Ltd. is a pharmaceutical enterprise specializing in the production of pharmaceutical raw materials and pharmaceutical intermediates. Its predecessor is Taizhou Jiaojiang Xingming chemical plant, which was founded in 1986.

At present, our company produces nearly 20 kinds of pharmaceutical intermediates and chemical products. The main products are adenine, clozapine, sulindac and intermediates.

Staff size:100-199 persons

Registered capital:RMB 2.28 million

Producer:Wuhan Shiji Pharmaceutical Co., Ltd. is a manufacturer dedicated to the R & D and production of chemical APIs. The company has established and implemented a complete quality management system, climbed to the world's top quality management level, and the quality system has been recognized by many well-known companies at home and abroad. The company has domestic pharmaceutical talents and has high-level technical force in drug R & D, production, registration and market development. The company's varieties have passed the official certification of FDA of the United States and EDQM of the European Union.

Staff size:About 50 persons

Registered capital:RMB 50 million

Producer:Huizhou Dongjiang Pharmaceutical Co., Ltd. (formerly Dongjiang pharmaceutical factory) was founded in 1984 and is subordinate to Huada Group Industrial Co., Ltd. Dongjiang pharmaceutical covers an area of 20000 square meters, with an annual output of 100 tons of clozapine. The cGMP of clozapine passed the FDA certification in April 2002.

Staff size:About 50 persons

Registered capital:RMB 3 million

Producer:Founded in 1993, Shouguang Fukang is a premier research and technology driven Chinese pharmaceutical enterprise with demonstrated capabilities for new drug research and development. It is ranked 42nd among China's Pharmaceutical Industry, employs 3,000 people and has a manufacturing campus of over 300 acres (2,000 Chinese acre).

Shouguang Fukang Pharmaceutical Co., Ltd. specializes in the development, manufacturing and marketing of 5 core product categories. They are PHARMACEUTCAL API, INTERMEDITES and FINISHED DOSE as well as BROMIDE COMPOUNDS and PAPER ADDITIVES, with a total of more than 60 products. Our production and sales volume of the API, trimethoprim (TMP), accounts for more than 70% of the world market. We are the No. 1 domestic producer and marketer of omeprazole, sulfamethoxazole (SMZ) and metformin HCl and the largest production base of bromide compounds. In a joint venture with BASF, we produce the following paper additives ; ODB-II, ODB-I, S-205 and EGTE, to the highest international standards.

Shouguang Fukang has established and implemented comprehensive quality assurance and quality control systems, with certifications of ISO9001/14001 and OHSAS18001. Shouguang Fukang was one of the first companies to receive SFDA GMP certification and five of our APIs, TMP, SMZ, omeprazole, metformin HCl and clozapine, have successfully passed USFDA inspection in Year 2011. We also gained COS certification from the European Directorate for the Quality of Medicines (EDQM). In addition we have successfully passed quality site audits from numerous renowned multinational corporations. Our company's products are domestically sold in 26 provinces and are exported to over 60 countries worldwide.

Staff size:1000-1999 persons

Registered capital:USD 156 million

Producer:Jinan Jinda Pharmaceutical Chemistry Co., Ltd. has 48 years of professional production history of chemical synthetic pharmaceutical APIs. It can produce 21 kinds of API and four kinds of intermediate products. Nineteen products have passed China GMP certification. It has passed the on-site inspection of FDA for five times. Furantoin series products are applying for CEP certificate, and DMF / edmf documents have been submitted for many varieties such as topidone hydrochloride and trisodium chloride.

Staff size:100-199 persons

Registered capital:RMB 1 million 769 thousand and 800

Producer:Founded in 1970, Wepon Pharmaceutical Group is a high-tech enterprise specializing in the R & D, production and sales of modern traditional Chinese medicine, chemical APIs and preparations. With a registered capital of 360 million yuan, it now has 6 subsidiaries, 192 drug production approval numbers and 16 dosage forms.

Staff size:500-599 persons

Registered capital:RMB 360 million